Globus Medical’s world is about to get a little bigger, as the orthopedic devicemaker moves to acquire Nevro and its ...

Analysts said Nevro’s valuation was “inexpensive,” but the spinal cord stimulation business can benefit from Globus’ scale ...

Jefferies analyst reiterated a Buy rating for Globus Medical (NYSE:GMED), with a steady price target of $105.00, following the company's announcement of its plans to acquire Nevro Corp . (NYSE:NVRO), ...

Globus Medical Inc. (NYSE:GMED), a medical device company with a market capitalization of $12 billion and an "GREAT" financial health rating according to InvestingPro, reaffirmed its commitment to ...

BTIG says Globus Medical’s (GMED) announced acquisition of Nevro (NVRO) “is surprising on the surface.” Investors did not expect Globus would ...

Stifel Globus Medical’s (GMED) announced acquisition of Nevro (NVRO) an “unexpected move.” The firm says that while it wants to be ...

On September 1 st, 2023, NuVasive was acquired by Globus Medical, a U.S.-based company specialized in musculoskeletal devices and implants 2. In view of their different strategic orientations ...

On September 1 st, 2023, NuVasive was acquired by Globus Medical, a U.S.-based company specialized in musculoskeletal devices and implants 2. In view of their different strategic orientations, SMAIO ...

Meanwhile, a court ruling on the Pataudi family's ₹15,000 crore historical properties poses a threat of government acquisition under the Enemy Property Act. The properties, including Flag Staff ...

With the complementary strengths of Globus Medical engineering and NuVasive relations, education and training, GMED aims to outpace market growth, leading to accelerated EPS growth and an increase ...